A novel vaccine (CoVac-1) currently in clinical trials in Germany induced T-cell immune responses in a large proportion of patients with blood cancers and B cell deficiencies.
Medscape Medical News
Novel COVID-19 Vaccine for Patients With Blood Cancers
